Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VBC106 in Advanced Malignant Solid Tumors
NCT07686068Phase 2Not yet recruiting
- Sponsor
- VelaVigo
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 2
01
Overview
A Phase 2 trial of VBC106 in solid tumor, sponsored by VelaVigo. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
VBC106
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07686068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07686068.